News Detail
New Delhi, 6 Nov 2021: A common diabetes drug can be used as an option for treating certain people with chronic kidney disease (CKD) in adults, claims a study published in the journal Lancet.
Dapagliflozin belongs to a group of medicines called ‘sodiu......
View Details
Source : Nagaland Post
Related News
- New process for polarity inversion of chemical compounds for precise drug synthesis (22-01-2025)
- Geometric machine learning method promises to accelerate precision drug development (20-01-2025)
- AI-Designed Antivenom Counteracts Toxins from Snakebites (17-01-2025)
- Researchers develop Quantum Dots that can help detect Antibiotics (17-01-2025)
- Feeding your good gut bacteria through fibre in diet may boost body against infections (13-01-2025)
- New combination drug offers treatment against intestinal worms: Lancet (13-01-2025)
- Researchers bypass the liver, delivering genetic drugs to the target location (01-01-2025)
- Study uses AI to cast light on harmful drug-drug interactions (16-12-2024)
- IIT-BHU developing med device with potential to cure sclerosis (28-11-2024)
- Three widely used BP medicines Combo, five times more effective than current drugs (19-11-2024)